Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. Biart (Liverpool, United Kingdom), K. Clayton (Macclesfield, United Kingdom), M. Babores (Macclesfield, United Kingdom), J. Gallagher (Macclesfield, United Kingdom), T. Nagarajan (Macclesfield, United Kingdom). A low cost, easily implementable method of shortening patient pathways in imaging incidentally suspicious for lung malignancy. 4815

Member's Comments

No comment yet.

Related content which might interest you: High performance and timely care of integrated FDG-PET and diagnostic CT in a rapid outpatient diagnostic program for suspected lung cancer patients Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 The impact of rapid on site evaluation of cytological specimens on a new endobronchial ultrasound (EBUS) service Source: Annual Congress 2011 - Are needles really enough? Year: 2011 Pre-PET CT FNA in the evaluation of solitary pulmonary nodules reduces the benign surgical resection rate in an area of high granulomatous disease incidence Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 A promising tool for T-staging of lung cancer: Is convex probe endobronchial ultrasound better than computerized tomography in determining invasion of mediastinal and hilar vessels? Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours? Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007 What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules Year: 2018 Timely diagnosis and therapy for suspected lung cancer patients in a 2 day rapid outpatient diagnostic program with integrated FGD-PET and diagnostic CT Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 EUS-FNA with on site pathologist results in a superior accuracy for ruling out mediastinal malignancy Source: Annual Congress 2005 - Screening and imaging of lung cancer Year: 2005 PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines Source: Annual Congress 2010 - State of the art imaging Year: 2010 VATS lung biopsy is the method of choice for patients with ambiguous pulmonary pathology to establish a morphologic diagnosis Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Nodal tissue diagnosis: do we need ultrasound? PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 In lung cancer screening by CT incidental findings are frequent and often of clinical importance Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 The Choice of lung biopsy method in the presence of limited focal lesions. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Combination of CT-guided core biopsy with rapid-on-site-evaluation of imprint cytology enables time and cost savings in diagnosis of peripheral lung tumors Source: Annual Congress 2012 - Solitary pulmonary nodules in the age of lung cancer screening: up and coming endoscopic options Year: 2012 Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012 Effect of a fast track CT pathway on diagnostic and treatment waiting times in lung cancer patients Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Combined endosonographic staging followed by cervical mediastinoscopy in the real world, do we still need both? Source: Annual Congress 2012 - EBUS-TBNA: a never ending story Year: 2012 Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007 Factors related to the diagnostic yield in use of virtual bronchoscopic navigation system for small peripheral pulmonary lesions Source: Annual Congress 2009 - Thoracoscopy and solitary pulmonary nodules Year: 2009